Clonogenic growth and enhanced cell migration are distinctive features of advanced tumors, suggesting that decreased CSGALNACT2 expression in ovarian neoplasms may potentially facilitate cancer progression. The gene discussed is CSGALNACT2; the disease is ovarian neoplasm.